Last updated: 2026-09-09 05:05:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Innoviva, Inc. (INVA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $21.34, with a market capitalization of $1.54B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.52 to $25.15. This page covers its latest market performance, valuation, price trends and company information.
$1.54B | |
$21.06 | |
$25.15 | |
$7.56 | |
$21.33 | |
584.81K | |
756.03K | |
-- | |
$25.15 | |
$16.52 | |
-- | |
-- |
Innoviva, Inc. (INVA) last closed at $21.33 as of 2026-09-08 23:31:00, unchanged from the previous close of $21.33.
During the latest regular trading session, INVA traded between $7.56 and $25.15, with a volume of 584.81K shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, Innoviva, Inc. (INVA) moved from $20.96 to $21.34, representing a gain of 1.81% ($0.38).
The stock traded between $20.68 and $21.81 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 638.25 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 55.9%
INVA is currently trading at $21.34, placing it 55.9% of the way from its 52-week low of $16.52 to its 52-week high of $25.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 159 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Innoviva, Inc. (INVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.